Showing results (1461-1470 of 3,085) with videos related to

Sort By:
Pageof 309
Drug Safety|March 20, 2010
Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007Lise Aagaard, Camilla Blicher Weber, Ebba Holme Hansen
Drug Safety|August 20, 2025
Navigating Medical Device Safety: Current Status, Challenges, and Future Regulatory DirectionsOmar Aimer, Catherine Baldridge
Drug Safety|February 24, 2023
Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin InfusionJillian H Hurst, Amanda Brucker, Congwen Zhao, et al.
Drug Safety|September 2, 2021
Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons LearnedMulugeta Russom, Iyassu Bahta, Merhawi Debesai
Drug Safety|February 22, 2023
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners' Reports 2013-22Harrison S France, Jeffrey K Aronson, Carl Heneghan, et al.
Drug Safety|November 17, 2022
Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety OutcomesSonal Singh, Julie Beyrer, Xiaofeng Zhou, et al.
Drug Safety|March 28, 2023
Core Data Elements for Pregnancy Pharmacovigilance Studies Using Primary Source Data Collection Methods: Recommendations from the IMI ConcePTION ProjectJonathan L Richardson, Alan Moore, Rebecca L Bromley, et al.
Drug Safety|March 12, 2025
The Frequency of Drug-Induced Liver Injury Due to Antibiotics Among Hospitalised PatientsRobert A Björnsson, Sigurdur Sölvi Sigurdsson, Dagur Tjörvi Arnarson, et al.
Drug Safety|February 14, 2025
Aggregation of Adverse Event Terms for Signal Detection and Labeling in Clinical TrialsRichard C Zink, Rebecca Lyzinski, Geoffrey Mann
Drug Safety|January 27, 2025
Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib ExampleSaad Hanif Abbasi, Lars Christian Lund, Jesper Hallas, et al.
Pageof 309